SERUM INTERLEUKIN-10 TITERS IN SYSTEMIC LUPUS-ERYTHEMATOSUS REFLECT DISEASE-ACTIVITY

被引:236
作者
HOUSSIAU, FA
LEFEBVRE, C
VANDENBERGHE, M
LAMBERT, M
DEVOGELAER, JP
RENAULD, JC
机构
[1] ST LUC UNIV HOSP,DEPT GEN INTERNAL MED,B-1200 BRUSSELS,BELGIUM
[2] UNIV CATHOLIQUE LOUVAIN,INT INST CELLULAR & MOLEC PATHOL,EXPTL MED UNIT,B-1200 BRUSSELS,BELGIUM
[3] UNIV CATHOLIQUE LOUVAIN,LUDWIG INST CANC RES,B-1200 BRUSSELS,BELGIUM
关键词
INTERLEUKIN-10; DISEASE ACTIVITY;
D O I
10.1177/096120339500400510
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated whether serum titers of interleukin 10 (IL-10), a cytokine known to shift lymphocyte responses towards humoral immunity, reflect disease activity in systemic lupus erythematosus (SLE). Sera from 72 SLE patients, 25 RA patients and 30 healthy controls were tested for IL-10 by ELISA. Low titers of IL-10 were detected in the serum of 37.5% of SLE patients and in 24% of RA patients but in only 3% of healthy controls. interestingly, serum IL-10 titers in SLE patients were positively correlated with the SLE Disease Activity Index (SLEDAI) and with anti-DNA antibody titers, but negatively with complement fraction C3 levels. These results indicate that serum IL-10 values reflect SLE disease activity and suggest that overexpression of IL-10 might play a pathogenic role in severe lupus disease.
引用
收藏
页码:393 / 395
页数:3
相关论文
共 13 条
[1]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[2]   ELEVATED INTERLEUKIN-10 LEVELS IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
CUSH, JJ ;
SPLAWSKI, JB ;
THOMAS, R ;
MCFARLIN, JE ;
SCHULZEKOOPS, H ;
DAVIS, LS ;
FUJITA, K ;
LIPSKY, PE .
ARTHRITIS AND RHEUMATISM, 1995, 38 (01) :96-104
[3]  
DEWIT D, 1993, J IMMUNOL, V150, P361
[4]   PRODUCTION OF INTERFERON-GAMMA, INTERLEUKIN-2, INTERLEUKIN-4, AND INTERLEUKIN-10 BY CD4+ LYMPHOCYTES INVIVO DURING HEALING AND PROGRESSIVE MURINE LEISHMANIASIS [J].
HEINZEL, FP ;
SADICK, MD ;
MUTHA, SS ;
LOCKSLEY, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7011-7015
[5]   CONTINUOUS ADMINISTRATION OF ANTI-INTERLEUKIN-10 ANTIBODIES DELAYS ONSET OF AUTOIMMUNITY IN NZB/W F1-MICE [J].
ISHIDA, H ;
MUCHAMUEL, T ;
SAKAGUCHI, S ;
ANDRADE, S ;
MENON, S ;
HOWARD, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :305-310
[6]  
KANNO K, 1992, ANN NY ACAD SCI, V651, P576
[7]  
LLORENTE L, 1993, EUR CYTOKINE NETW, V4, P421
[8]   ROLE OF INTERLEUKIN-10 IN THE B-LYMPHOCYTE HYPERACTIVITY AND AUTOANTIBODY PRODUCTION OF HUMAN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
LLORENTE, L ;
ZOU, WP ;
LEVY, Y ;
RICHAUDPATIN, Y ;
WIJDENES, J ;
ALCOCERVARELA, J ;
MORELFOURRIER, B ;
BROUET, JC ;
ALARCONSEGOVIA, D ;
GALANAUD, P ;
EMILIE, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :839-844
[9]   IN-VIVO PRODUCTION OF INTERLEUKIN-10 BY NON-T CELLS IN RHEUMATOID-ARTHRITIS, SJOGRENS-SYNDROME, AND SYSTEMIC LUPUS-ERYTHEMATOSUS - A POTENTIAL MECHANISM OF B-LYMPHOCYTE HYPERACTIVITY AND AUTOIMMUNITY [J].
LLORENTE, L ;
RICHAUDPATIN, Y ;
FIOR, R ;
ALCOCERVARELA, J ;
WIJDENES, J ;
FOURRIER, BM ;
GALANAUD, P ;
EMILIE, D .
ARTHRITIS AND RHEUMATISM, 1994, 37 (11) :1647-1655
[10]  
MALEFYT RD, 1991, J EXP MED, V174, P1209